Johns Hopkins Drug Discovery - John Hopkins University
The Johns Hopkins Drug Discovery Program continues to work with the researchers across Johns Hopkins to research and develop tomorrow’s therapeutics for a wide range of human disorders.
Johns Hopkins, Drug Discovery, Transforming academic translational research
2
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-2,bridge-core-3.0.5,qi-blocks-1.0.6,qodef-gutenberg--no-touch,qodef-qi--no-touch,qi-addons-for-elementor-1.5.5,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-29.1,qode-theme-bridge,disabled_footer_bottom,wpb-js-composer js-comp-ver-6.9.0,vc_responsive,elementor-default,elementor-kit-3247,x-shortcodes-v3_0_5
Johns Hopkins University Drug Discovery

Transforming academic
translational research

Expertise in drug
discovery research

Developing for the future

What’s New?

JHDD Director Barbara Slusher, Rana Rais, and Diane Peters interviewed for Medical Breakthrough TV series – “The Accidental Discovery to Treat IBD”
Watch the video

Sun Pharma Advanced Research Company (SPARC) in-licenses a novel prodrug to treat autoimmune-related hair loss

Barbara Slusher celebrates 10 years of innovation with JH Technology Ventures

Watch the interview

JHDD and Bloomberg-Kimmel Institute for Cancer Immunotherapy researchers partner on drug that helps suppress prostate and bladder tumor growth.

Blackbird Laboratories, funded by the Bisciotti Foundation, partners with JHDD to develop IBD treatment

Read the article from the Baltimore Banner

JHDD researchers develop gut-restricted drug to treat IBD

Building innovative partnerships

Johns Hopkins University Drug Discovery - JHU Drug Discovery

Our high throughput screening collaboration with Eisai represents an innovative way to create synergy between complimentary organizations to develop new therapeutics.

Interested in Working With Us?

We welcome opportunities to discuss how we can work together in a drug discovery collaboration.